Evidence map›Paper›PMID 34903448›Full record

ArticleEuropean journal of internal medicine2022

Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study.

Carlo Fumagalli, Chiara Zocchi, Luigi Tassetti, Maria Vittoria Silverii, Carla Amato, Luca Livi, Lorenzo Giovannoni, Federica Verrillo, Alessandro Bartoloni, Rossella Marcucci and 8 more

Open access · greenAbstract read
In one paragraph

Article in European journal of internal medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed, 6 pooled it
9.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 6 syntheses or guidelines pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Long-Term Consequences of COVID-19 at 6 Months and Above: A Systematic Review and Meta-Analysis.International journal of environmental research and public health · 2022
    Pooled it
  7. Article
  8. Article
  9. Article
  10. Article
  11. 'We Don't Have to Prove to People How We're Feeling': Understanding the Role of Peer Support Groups in Countering Epistemic Injustices in Long COVID at a US Centre.Health expectations : an international journal of public participation in health care and health policy · 2025
    Article
  12. Article
  13. Article
  14. Long-term Effects of COVID-19 on Sleep PatternsThoracic research and practice · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Illness presentation and quality of life in myalgic encephalomyelitis/chronic fatigue syndrome and post COVID-19 condition: a pilot Australian cross-sectional study.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2024
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 1 institution in 1 country.

Carlo FumagalliDepartment of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy. Electronic address: 00.carlo@gmail.com.
Chiara ZocchiDepartment of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.
Luigi TassettiDepartment of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.
Maria Vittoria SilveriiDepartment of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.
Carla AmatoDepartment of Public Health, University of Florence, Florence, Italy.
Luca LiviDepartment of Public Health, University of Florence, Florence, Italy.
Lorenzo GiovannoniDepartment of Public Health, University of Florence, Florence, Italy.
Federica VerrilloDepartment of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.
Alessandro BartoloniDepartment of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.
Rossella MarcucciDepartment of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.
Federico LavoriniDepartment of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.
Stefano FumagalliDepartment of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.
Andrea UngarDepartment of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.
Iacopo OlivottoDepartment of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.
Laura RaseroDepartment of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.
Francesco FattirolliDepartment of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.
Niccoló MarchionniDepartment of Experimental and Clinical Medicine, University of Florence and AOU Careggi, Florence, Italy.
AOU Careggi COVID-19 Follow-up study Group
University of Florence · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the persistence of symptoms compatible with COVID-19 in a real-file prospective cohort of patients at 12 months from hospital discharge.

methodsLongitudinal, prospective, single-center, cohort telephone follow-up (FU) study in a Tertiary Care Hospital. All consecutive patients >18 years admitted for COVID-19 were prospectively enrolled in a telephone FU program aimed at monitoring symptoms after 1,3,6,9 and 12 months from hospital discharge. The survey screened for somatic (fatigue, dyspnea, dyspnea, palpitations, cough, chest pain, abdominal pain, ageusia, anosmia, bowel symptoms) and emotional symptoms (insomnia, confusion, altered sense of reality, loss of appetite, fear, and depression) and frailty. Only patients with 12 months FU data were analyzed (N=254). Prevalence and factors associated with symptoms were the main outcomes. Frailty was defined by the presence of ≥3 indicators: weakness, slowness/impaired mobility, weight-loss, low physical activity, and exhaustion.

resultsAt 12 months, 40.5% of patients reported at least one symptom. The most common somatic ones were fatigue, exertional dyspnea, cough, bowel complaints while the most common psycho-emotional were insomnia, confusion, fear, and depression. Age, gender, gender, frailty, multiple symptoms at baseline and chronic obstructive pulmonary disease (COPD) were associated with symptoms persistence. Furthermore, frailty, COPD and multiple symptoms at baseline were associated with increased risk of somatic symptoms at 12 months, while age and gender were associated with emotional ones.

conclusionsBurden of the long COVID-19 symptoms decreased over time but remained as high as 40% at 12 months with important gender and functional differences, highlighting potential patient categories who may benefit from specific follow up strategies.

Indexed as

COVID-19Cohort StudiesFollow-Up StudiesHumansPost-Acute COVID-19 SyndromeProspective StudiesSARS-CoV-2COVID-19FrailtyGender medicineLong-COVIDPrognosisSymptoms

Identifiers

PMID34903448
PMCPMC8648678
OpenAlexW4200426130

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.